BROKEN STRING BIOSCIENCES

Summary

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 12 M

Avg. Deal Size£ 12 M

Market Context

Senior Management

Felix Dobbs
CEO